QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

INTRODUCTION: Substantial preclinical evidence has indicated that inhibition of integrin linked-kinase (ILK) correlates with cytotoxic/cytostatic cellular effects, delayed tumor growth in animal models of cancer, and inhibition of angiogenesis. Widely anticipated to represent a very promising therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Jessica, Warburton, Corinna, Fang, Karen, Edwards, Lincoln, Daynard, Tim, Waterhouse, Dawn, Dragowska, Wieslawa, Sutherland, Brent W, Dedhar, Shoukat, Gelmon, Karen, Bally, Marcel
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716491/
https://www.ncbi.nlm.nih.gov/pubmed/19409087
http://dx.doi.org/10.1186/bcr2252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716491/
https://www.ncbi.nlm.nih.gov/pubmed/19409087
http://dx.doi.org/10.1186/bcr2252

Ejemplares similares